Willingness to provide biopsy samples for research purposes (patients >=  years of age at the National Cancer Institute [NCI] Clinical Center only)
Willingness to release archival tissue sample for research purposes, if available
. Willingness to provide consent for biopsy samples;
Willingness to provide mandatory blood samples for research purposes
Willingness to provide blood and new tumor biopsy samples for research purposes if on the expansion phase of the study
Willingness to provide blood and new tumor biopsy samples for research purposes if on the expansion phase of the study
Willingness to provide blood and urine samples for research purposes
Patient must be willing to provide mandatory tissue samples (unstained slides) for research purposes
Be willing to provide blood and tissue samples for research purposes\r\n* Blood and tissue leftover from protocol specified analyses and those collected not specifically for protocol defined research require optional consent for retaining for unspecified research purposes
Willingness to provide blood and biopsy samples for research purposes if on the expansion phase of the study
The presence of disease that can be biopsied for research purposes is not an inclusion criterion
Subjects must agree to allow use of any pre-treatment tissue remaining after definitive diagnosis is made (ie, archival and or fresh tissue) for research purposes; in addition, subjects must consent to allow use of their residual post-operative tissue for research purposes
Consent for tumor biopsies (for patients enrolled in stage  only) and blood draws for research purposes (for all patients)
Consent for use of available archived tissue and tumor obtained during a standard procedure, for research purposes
Has existing archived tissue and is willing to consent to providing sample for correlative research purposes
Willing to provide consent for an additional tissue biopsy for research purposes, to allow a part of their surgical tumor tissue to be utilized for research (in case tumor tissue has not already been saved in the tumor tissue bank), and to donate samples of blood and saliva collected weekly through the treatment
UROTHELIAL CARCINOMA EXPANSION COHORT: Willingness to release archival tissue sample for research purposes, if available
Willing to provide mandatory tissue samples for research purposes
Willing to provide mandatory tissue and blood samples for research purposes\r\n* NOTE: Patients must be willing to provide at the time surgical resection; for patients who do not undergo surgery, any on-study tumor biopsy obtained for clinical purposes subsequent to the baseline biopsy must also be available for analysis
Consent for use of archived tissue for research purposes
Willingness to provide consent for use of archived tissue for research purposes
Ability to understand and the willingness to sign a written informed consent document, and willing to provide blood samples before and during preoperative therapy; patients are also asked but not required to have research biopsies performed before and after therapy
Willingness to provide pre- and post-treatment tissue for translational studies. Pre-treatment fresh frozen tissue must be available for research purposes. This tissue can be collected from preoperative laparoscopy, other diagnostic biopsy, or a research-specific biopsy.
Willingness to provide blood and tissue samples for correlative research purposes; (Note: these tissue samples are from archived tissue, if available; new biopsies are not required)
Willing to provide blood and tissue (can be archival) samples for mandatory research purposes
The participant is willing to provide blood, urine, and tissue samples for research purposes.
Willing to provide tissue for research purposes
Willing to provide tissue for translational research
Are willing to provide blood/serum/plasma and tumor tissue samples for research purposes. Submission of blood/serum/plasma and tumor tissue samples is mandatory for participation in this study, unless restricted per local regulations.
Consent for blood draws for research purposes
Consent for use of available archived tissue for research purposes
If patient has a clinically indicated surgery or biopsy at any time during treatment with Reolysin, a tissue sample will be collected for correlative research purposes
Consent for tumor biopsies and blood draws for research purposes
Consent for use of available archived tissue for research purposes
Willingness to release and confirmed availability of archival tissue sample for research purposes
Willing to provide tissue and blood samples for mandatory banking purposes
Willing to provide tissue samples for research purposes
Mayo Rochester patients only: willingness to provide mandatory blood samples for research purposes
Willingness to provide blood samples for immune assessment and other tests
Willingness to provide blood and tissue samples as required per protocol
Willing to provide tissue for research purposes
Patients must be willing to consent to tumor biopsy for research purposes
Willingness to provide blood and tissue samples for research studies as required by the protocol
Willingness to provide consent for biopsy samples
Patients with multicentric or bilateral disease are eligible if the target lesions meet the other eligibility criteria; samples from all available tumors are requested for research purposes
Available tissue for AR testing for research purposes
Willing to provide blood samples for research purposes (Mayo Clinic sites only).
Willing to undergo post-NAC, pre-treatment biopsy for research purposes only, and to allow surgical tissue sample from definitive surgery to be used for research purposes
Be willing to provide blood and tissue samples for research purposes (blood and tissue leftover from protocol specified analyses and those collected not specifically for protocol defined research require optional consent for retaining for unspecified research purposes)
Willingness to provide mandatory  hour urine collection samples for research purposes
Pre-treatment fresh frozen tissue available for research purposes; this tissue can be collected from preoperative laparoscopy, other diagnostic biopsy, or a research-specific biopsy
Willingness to provide tissue and blood samples for mandatory translational research
Willing to provide blood for research.
Willingness to provide blood samples for research tests specified in the protocol
Willingness to provide mandatory tissue for research purposes
Willingness to provide tissue samples for research purposes
Willingness to provide blood samples for toxicity monitoring and research purposes
Willingness to provide blood and tissue specimens for research purposes
Willing to allow use or collection of pathology tissue for the purposes of research from either clinical biopsy or surgical procedure (if adequate tissue is available) or research only biopsy
Patients with multicentric disease are eligible. Samples from all available tumors are requested for research purposes
Patients must be willing to provide  mL of blood for research use
Patient must be willing to provide consent for use of archived tissue for research
DYNAMIC COHORT: Willing to consent to collection of pathology tissue for the purposes of research at the time of clinical biopsy or surgical procedure
